Catalyst Wire Dossier Catalyst Wire Dossier

AG

Drug timelines are a Plus or Pro feature.

11 regulatory and trial events tracked for AG, covering 2018-08-22 to 2025-12-24. Get the full timeline:

Most recent: Clinical Trial Update: Tunlametinib + AG + Cetuximab β as First-Line Therapy for Advanced Pancreatic Cancer [Phase 4]

See pricing